A carregar...
The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn’s Disease
Vedolizumab is a humanized monoclonal α4β7 integrin antibody used in patients with Crohn’s disease (CD) and ulcerative colitis (UC). Limited data are available on the use of vedolizumab in patients with concurrent cirrhosis and inflammatory bowel disease (IBD). Patients with cirrhosis are unique, as...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168050/ https://ncbi.nlm.nih.gov/pubmed/30305988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3080 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|